At a glance
ClinicalIndex Comparison RecordN/ACompleted· 54 enrolled
Drug / intervention
MSOT Device +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Feasibility Study for the Use of Multispectral Optoacoustic Tomography in the Detection of Solid Tumors and Lymph Nodes (MSOT)
In Brief
A clinical study evaluating MSOT Device and Temperature Measurement for Solid Tumor. Completed, enrolled 54 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the safety and potential of a new experimental imaging instrument called multispectral optoacoustic tomography (MSOT) to detect tumors and lymph nodes with tumors.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSolid Tumor
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedApr 2020
Enrollment StartJul 2020
Primary CompletionJul 2021
Study CompletionDec 2022
TodayJul 2026
First PostedApr 28, 2020
Enrollment StartJul 22, 2020
Primary CompletionJul 12, 2021
Study CompletionDec 12, 2022
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 6.2 years ago
Interventions
MSOT Devicedevice
The MSOT Device will be used to take images of the tumor and/or lymph nodes of patients with solid tumors before and after surgery to measure the margins of the tumor and/or positive lymph node.
Temperature Measurementprocedure
The temperature of the skin will be measured prior to and after MSOT imaging.